Stockreport

Ventyx Biosciences Announces Departure of Chief Financial Officer

Ventyx Biosciences, Inc.  (VTYX) 
PDF SAN DIEGO, Aug. 30, 2024 (GLOBE NEWSWIRE) --  Ventyx Biosciences, Inc. (Nasdaq: VTYX) (“Ventyx”), a clinical-stage biopharmaceutical company focused on advancing novel [Read more]